| Dr Isaac George Isaac, MD | |
|
1750 17th St Building N, Sarasota, FL 34234-8690 | |
| (813) 390-2977 | |
| Not Available |
| Full Name | Dr Isaac George Isaac |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 1750 17th St Building N, Sarasota, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063681773 | NPI | - | NPPES |
| 003750900 | Medicaid | FL | |
| 14AK9 | Other | FL | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | ME105660 (Florida) | Secondary |
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | ME105660 (Florida) | Primary |
| Entity Name | Centerplace Health, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104316272 PECOS PAC ID: 4587912860 Enrollment ID: O20181121002527 |
News Archive
Rowan University and Bamboo Therapeutics, Inc. have entered into an asset transfer agreement to commercialize a novel gene therapy for the treatment of Canavan disease. A rare but devastating neurological disease that tragically takes a child's life by age 10, Canavan disease is one of the most common and complex degenerative cerebral diseases in infants.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced financial results and operational highlights for the quarter ended September 30, 2009. For the third quarter of 2009, Auxilium reported net revenues of $42.1 million compared to net revenues of $32.6 million in the third quarter of 2008.
President Barack Obama continued to lament the problems plaguing the federal online insurance marketplace, but he also scolded the Texas government for its resistance to the health law's Medicaid expansion, which, he said, left more than a million of the state's people uninsured.
Tulane University's Stryder Meadows, a cell and molecular biology professor, received a $1.7 million grant from the Department of Defense to study how arteriovenous malformations (AVM), which are defects in arteries, veins and capillaries, form Hereditary Hemorrhagic Telangiectasia (HHT), a genetic disorder that affects about 1 in 5,000 people.
Cardiac patients can benefit from home-based high intensity training, even without the support of fancy training equipment or a clinic, new research from the Norwegian University of Science and Technology has shown.
› Verified 6 days ago
| Entity Name | Hni Medical Services Of Florida, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679048284 PECOS PAC ID: 7517202112 Enrollment ID: O20190102000426 |
News Archive
Rowan University and Bamboo Therapeutics, Inc. have entered into an asset transfer agreement to commercialize a novel gene therapy for the treatment of Canavan disease. A rare but devastating neurological disease that tragically takes a child's life by age 10, Canavan disease is one of the most common and complex degenerative cerebral diseases in infants.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced financial results and operational highlights for the quarter ended September 30, 2009. For the third quarter of 2009, Auxilium reported net revenues of $42.1 million compared to net revenues of $32.6 million in the third quarter of 2008.
President Barack Obama continued to lament the problems plaguing the federal online insurance marketplace, but he also scolded the Texas government for its resistance to the health law's Medicaid expansion, which, he said, left more than a million of the state's people uninsured.
Tulane University's Stryder Meadows, a cell and molecular biology professor, received a $1.7 million grant from the Department of Defense to study how arteriovenous malformations (AVM), which are defects in arteries, veins and capillaries, form Hereditary Hemorrhagic Telangiectasia (HHT), a genetic disorder that affects about 1 in 5,000 people.
Cardiac patients can benefit from home-based high intensity training, even without the support of fancy training equipment or a clinic, new research from the Norwegian University of Science and Technology has shown.
› Verified 6 days ago
| Entity Name | Doctors Isaac & Isaac Psychiatric Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679202618 PECOS PAC ID: 7214313170 Enrollment ID: O20220929001192 |
News Archive
Rowan University and Bamboo Therapeutics, Inc. have entered into an asset transfer agreement to commercialize a novel gene therapy for the treatment of Canavan disease. A rare but devastating neurological disease that tragically takes a child's life by age 10, Canavan disease is one of the most common and complex degenerative cerebral diseases in infants.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced financial results and operational highlights for the quarter ended September 30, 2009. For the third quarter of 2009, Auxilium reported net revenues of $42.1 million compared to net revenues of $32.6 million in the third quarter of 2008.
President Barack Obama continued to lament the problems plaguing the federal online insurance marketplace, but he also scolded the Texas government for its resistance to the health law's Medicaid expansion, which, he said, left more than a million of the state's people uninsured.
Tulane University's Stryder Meadows, a cell and molecular biology professor, received a $1.7 million grant from the Department of Defense to study how arteriovenous malformations (AVM), which are defects in arteries, veins and capillaries, form Hereditary Hemorrhagic Telangiectasia (HHT), a genetic disorder that affects about 1 in 5,000 people.
Cardiac patients can benefit from home-based high intensity training, even without the support of fancy training equipment or a clinic, new research from the Norwegian University of Science and Technology has shown.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Isaac George Isaac, MD 1750 17th St Building N, Sarasota, FL 34234-8690 Ph: () - | Dr Isaac George Isaac, MD 1750 17th St Building N, Sarasota, FL 34234-8690 Ph: (813) 390-2977 |
News Archive
Rowan University and Bamboo Therapeutics, Inc. have entered into an asset transfer agreement to commercialize a novel gene therapy for the treatment of Canavan disease. A rare but devastating neurological disease that tragically takes a child's life by age 10, Canavan disease is one of the most common and complex degenerative cerebral diseases in infants.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced financial results and operational highlights for the quarter ended September 30, 2009. For the third quarter of 2009, Auxilium reported net revenues of $42.1 million compared to net revenues of $32.6 million in the third quarter of 2008.
President Barack Obama continued to lament the problems plaguing the federal online insurance marketplace, but he also scolded the Texas government for its resistance to the health law's Medicaid expansion, which, he said, left more than a million of the state's people uninsured.
Tulane University's Stryder Meadows, a cell and molecular biology professor, received a $1.7 million grant from the Department of Defense to study how arteriovenous malformations (AVM), which are defects in arteries, veins and capillaries, form Hereditary Hemorrhagic Telangiectasia (HHT), a genetic disorder that affects about 1 in 5,000 people.
Cardiac patients can benefit from home-based high intensity training, even without the support of fancy training equipment or a clinic, new research from the Norwegian University of Science and Technology has shown.
› Verified 6 days ago
Valeriy Sabodash, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5741 Bee Ridge Rd Ste 530, Sarasota, FL 34233 Phone: 941-487-2160 Fax: 941-487-2170 | |
Dr. Enrico V Vintayen, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1700 S Tamiami Trl, Sarasota, FL 34239 Phone: 941-917-4896 Fax: 941-917-6884 | |
Eyad Almallouhi, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1921 Waldemere St Ste 607, Sarasota, FL 34239 Phone: 941-262-3100 Fax: 941-261-3760 | |
Ajay Mayor, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6400 Edgelake Dr, Sarasota, FL 34240 Phone: 941-921-8600 | |
Dr. Vladimir Einisman, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2750 Bahia Vista St, Suite 200, Sarasota, FL 34239 Phone: 941-284-9635 Fax: 941-952-1756 | |
Dr. Stephen George Huk, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 6075 Rand Blvd Ste 1, Sarasota, FL 34238 Phone: 941-921-2792 Fax: 941-925-2738 | |
Michael D Healy, PSYD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 235 N Orange Ave Ste 102, Sarasota, FL 34236 Phone: 941-923-9533 |